These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 21320055)

  • 1. The protein-protein interactions as a target in medicinal chemistry and drug discovery.
    Mustata G
    Curr Top Med Chem; 2011; 11(3):247. PubMed ID: 21320055
    [No Abstract]   [Full Text] [Related]  

  • 2. Modulation of protein-protein interactions as a therapeutic strategy for the treatment of neurodegenerative tauopathies.
    Ballatore C; Brunden KR; Trojanowski JQ; Lee VM; Smith AB; Huryn DM
    Curr Top Med Chem; 2011; 11(3):317-30. PubMed ID: 21320060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ChemGPS-NP(Web): chemical space navigation online.
    Rosén J; Lövgren A; Kogej T; Muresan S; Gottfries J; Backlund A
    J Comput Aided Mol Des; 2009 Apr; 23(4):253-9. PubMed ID: 19082743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pyrrolotetrazinones deazaanalogues of temozolomide induce apoptosis in Jurkat cell line: involvement of tubulin polymerization inhibition.
    Viola G; Cecconet L; Leszl A; Basso G; Brun P; Salvador A; Dall'Acqua F; Diana P; Barraja P; Cirrincione G
    Cancer Chemother Pharmacol; 2009 Nov; 64(6):1235-51. PubMed ID: 19363609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IAP antagonists: promising candidates for cancer therapy.
    Mannhold R; Fulda S; Carosati E
    Drug Discov Today; 2010 Mar; 15(5-6):210-9. PubMed ID: 20096368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increasing the range of drug targets: interacting peptides provide leads for the development of oncoprotein inhibitors.
    Groner B; Weber A; Mack L
    Bioengineered; 2012; 3(6):320-5. PubMed ID: 22825353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Promoting apoptosis as a strategy for cancer drug discovery.
    Fesik SW
    Nat Rev Cancer; 2005 Nov; 5(11):876-85. PubMed ID: 16239906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel nicotinoyl pyrazoline derivates bearing N-methyl indole moiety as antitumor agents: Design, synthesis and evaluation.
    Chen K; Zhang YL; Fan J; Ma X; Qin YJ; Zhu HL
    Eur J Med Chem; 2018 Aug; 156():722-737. PubMed ID: 30041136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitors of apoptosis: clinical implications in cancer.
    Mohamed MS; Bishr MK; Almutairi FM; Ali AG
    Apoptosis; 2017 Dec; 22(12):1487-1509. PubMed ID: 29067538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of novel 2-phenyl-imidazo[1,2-a]pyridine analogues targeting tubulin polymerization as antiproliferative agents.
    An W; Wang W; Yu T; Zhang Y; Miao Z; Meng T; Shen J
    Eur J Med Chem; 2016 Apr; 112():367-372. PubMed ID: 26927488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting survivin for therapeutic discovery: past, present, and future promises.
    Peery RC; Liu JY; Zhang JT
    Drug Discov Today; 2017 Oct; 22(10):1466-1477. PubMed ID: 28577912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. QSAR and 3D-QSAR models in the field of tubulin inhibitors as anticancer agents.
    Marzaro G; Chilin A
    Curr Top Med Chem; 2014; 14(20):2253-62. PubMed ID: 25434357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tubulin: an example of targeted chemotherapy.
    Seligmann J; Twelves C
    Future Med Chem; 2013 Mar; 5(3):339-52. PubMed ID: 23464522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The synthesis and evaluation of new butadiene derivatives as tubulin polymerization inhibitors.
    Pang Y; Yan J; An B; Huang L; Li X
    Bioorg Med Chem; 2017 Jun; 25(12):3059-3067. PubMed ID: 28404525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 2-Aminothiazole: A privileged scaffold for the discovery of anti-cancer agents.
    Wan Y; Long J; Gao H; Tang Z
    Eur J Med Chem; 2021 Jan; 210():112953. PubMed ID: 33148490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Indole molecules as inhibitors of tubulin polymerization: potential new anticancer agents, an update (2013-2015).
    Patil R; Patil SA; Beaman KD; Patil SA
    Future Med Chem; 2016 Jul; 8(11):1291-316. PubMed ID: 27476704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of Cell Death and Disease: Advances in Therapeutic Intervention and Drug Discovery--ESH's Eighth International Conference. October 14-17, 2010, Cascais, Portugal.
    Vucic D
    IDrugs; 2010 Dec; 13(12):836-9. PubMed ID: 21154138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quinazolinone analogs as potential therapeutic agents.
    Sharma PC; Kaur G; Pahwa R; Sharma A; Rajak H
    Curr Med Chem; 2011; 18(31):4786-812. PubMed ID: 21919847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel synthetic compound exerts effective anti-tumour activity in vivo via the inhibition of tubulin polymerisation in A549 cells.
    Yan J; Pang Y; Sheng J; Wang Y; Chen J; Hu J; Huang L; Li X
    Biochem Pharmacol; 2015 Sep; 97(1):51-61. PubMed ID: 26212540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent Applications of Benzimidazole as a Privileged Scaffold in Drug Discovery.
    Guo Y; Hou X; Fang H
    Mini Rev Med Chem; 2021; 21(11):1367-1379. PubMed ID: 32753010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.